▲ BUY
10
/ 10
Conviction
$ Value
$700K
Shares
25,000
Price
$28
Filed
Apr 20
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 50% (+3)
- ✓ Director (+1)
- ✓ Cluster: 7 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Oetgen Stephen Duane
Title
—
CIK
0002126570
Roles
Director
Transaction Details
Transaction Date
2026-04-17
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
30,357
Footnotes
Represents an award of restricted stock units with respect to Class A Common Stock which will vest on the first anniversary of the grant date. | Represents shares of Class A Common Stock purchased by the Reporting Person through the directed share program conducted in connection with the Issuer's initial public offering.
Filing Info
Oetgen Stephen Duane's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | ARXS | A | $0 |
| 2026-04-17 | ARXS | ▲ | $700K ★ |
Other Insiders at ARXS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Roth Jason Aaron
See Remarks
|
$1.7M | — | 2026-04-17 |
|
Perhamus Kevin Scott
See Remarks
|
$1.5M | — | 2026-04-17 |
|
Badakhsh Azad Sid
See Remarks
|
$1.0M | — | 2026-04-17 |
|
Sealfon Ross Bradley
See Remarks
|
$350K | — | 2026-04-17 |
| ALLEN PATRICK E | $280K | — | 2026-04-17 |
|
Jankowski Ryan Anthony
Chief Accounting Officer
|
$125K | — | 2026-04-17 |
|
Allen Jennifer H.
See Remarks
|
— | — | 2026-04-16 |
| Oetgen Stephen Duane | — | — | 2026-04-17 |
| Arcline Double Eagle Master Fund-A LP | — | — | 2026-04-16 |